Oligella ureolytica in blood culture: contaminant or infection?
Lechner
A
A
Department of Medicine III, General Hospital Salzburg, Austria. A.Lechner@lks.at
Bruckner
D A
DA
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017963:Azithromycin / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D002444:Cefuroxime / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D006089:Gram-Negative Anaerobic Bacteria / Q000302:isolation & purification*; D016905:Gram-Negative Bacterial Infections / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D007223:Infant; D008297:Male; D011014:Pneumonia / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D002443:Ceftriaxone; D017963:Azithromycin; D002444:Cefuroxime